2022-08-22
Innovaderm extends a warm welcome to Dr. Jankicevic, a key opinion leader in the field of dermatology drug/device development and medical affairs who will oversee our global clinical development and medical strategy.
To learn more: https://lnkd.in/gSRi3Ts9
We are excited to announce our participation in the upcoming AID’s Dermatology Summit in San Francisco, taking place on January 12th, 2025. This prestigious event brings together leading experts, researchers, and practitioners in the field of dermatology to share the latest advancements and innovations. As long-time sponsors of this summit, we are proud to continue […]
[MONTREAL, QC, November 19th, 2024]—Innovaderm, a leading clinical research organization (CRO) specializing in dermatology and rheumatology, is pleased to announce the appointment of Ina Zschocke, as the new Executive Vice President, European Operations and Strategy. This strategic hire underscores Innovaderm’s commitment to expanding its ever-growing presence and capabilities in the European market. Ina Zschocke, PhD, […]
Innovaderm is thrilled to announce that it's Chief Medical Officer, Dr. Jasmina Jankicevic, will be chairing Pharmaceutical Business Conference Group's (PBC Group) Clinical Outsourcing Group: CRO Summit on December 3rd & 4th, 2024. The Future of Clinical Research: Summit Chair Jasmina Jankicevic Weighs in on CRO Evolution - Read the interview now to learn on the changing environment for clinical […]
